A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge-Reference-Cited by-同舟云学术

A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge

Published:2017-09 Issue: Volume:509 Page:60-66
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Russell Charles J.,Jones Bart G.,Sealy Robert E.,Surman Sherri L.,Mason John N.,Hayden Randall T.,Tripp Ralph A.,Takimoto Toru,Hurwitz Julia L.

Funder

NIH

Publisher

Elsevier BV

Subject

Virology

Reference40 articles.

1. Safety and immunogenicity of an intranasal Sendai virus-based parainfluenza virus type 1 vaccine in 3-6 year old children;Adderson;Clin. Vaccine Immunol.,2014

2. Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains;Bastien;Virus Res.,2003

3. Modification of the trypsin-dependent cleavage activation site of the human metapneumovirus fusion protein to be trypsin independent does not increase replication or spread in rodents or nonhuman primates;Biacchesi;J. Virol.,2006

4. Genetic diversity between human metapneumovirus subgroups;Biacchesi;Virology,2003

5. Global genetic diversity of human metapneumovirus fusion gene;Boivin;Emerg. Infect. Dis.,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure, Immunogenicity, and Conformation-Dependent Receptor Binding of the Postfusion Human Metapneumovirus F Protein;Journal of Virology;2021-08-25

2. Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses;Viruses;2021-05-29

3. Structure, immunogenicity, and conformation-dependent receptor binding of the post-fusion human metapneumovirus F protein;2021-05-19

4. Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults;Human Vaccines & Immunotherapeutics;2020-08-04

5. Prospects of and Barriers to the Development of Epitope-Based Vaccines against Human Metapneumovirus;Pathogens;2020-06-18